Clinical data | |
---|---|
Trade names | Estrovis, others |
Other names | Quinoestrol; Quinestrenol; Quinoestrenol; Ethinylestradiol 3-cyclopentyl ether; EECPE; EE2CPE; W-3566; 3-(Cyclopentyloxy)-17α-ethynylestra-1,3,5(10)-trien-17β-ol |
AHFS/Drugs.com | Micromedex Detailed Consumer Information |
Routes of administration | By mouth |
Drug class | Estrogen; Estrogen ether |
ATC code |
|
Pharmacokinetic data | |
Elimination half-life | >120 hours (>5 days)[1] |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
IUPHAR/BPS | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.005.277 |
Chemical and physical data | |
Formula | C25H32O2 |
Molar mass | 364.529 g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
Quinestrol, also known as ethinylestradiol cyclopentyl ether (EECPE), sold under the brand name Estrovis among others, is an estrogen medication which has been used in menopausal hormone therapy, hormonal birth control, and to treat breast cancer and prostate cancer.[2][3] It is taken once per week to once per month by mouth.[4][5][6][7]
Sitruk-Ware_2012
was invoked but never defined (see the help page).Peterson_1999
was invoked but never defined (see the help page).Quirk_2012
was invoked but never defined (see the help page).HorskyPresl2012
was invoked but never defined (see the help page).HawkinsElder2013
was invoked but never defined (see the help page).Bennett_1974
was invoked but never defined (see the help page).